Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CYSTEAMINE HYDROCHLORIDE
- PK and PD Study of NPI-001 and Cysteamine Bitartrate
- Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19
- Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
- TTI-0102 for Veterans With TBI
- NBMI Treatment in Patients With Mercury Toxicity
- Cysteamine for Asthma
- A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
- Efficacy of Topical Cysteamine in Nephropathic Cyctinosis
- A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
- First Study of Oral Cysteamine in Cystic Fibrosis
- Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis
- Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)
- Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
- Safety/Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis
- Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis
- Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
- Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™
- Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)
- An Open Trial of Cysteamine Treatment in Schizophrenia
- Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
- Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis
- A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)
- Cysteamine Therapy for Major Depressive Disorder
- Use of Cysteamine in the Treatment of Cystinosis
- Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis
- Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
- A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease
- New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis
- Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis
Clinical trials list
click for details